Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-02-16
2011-12-06
Shameem, Golam M M (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S316400, C548S325100, C514S385000, C514S386000, C546S112000, C546S152000
Reexamination Certificate
active
08071635
ABSTRACT:
Compounds of Formula 1where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2Band/or alpha2Cadrenergic receptors in preference over alpha2Aadrenergic receptors, and as such have no or only minimal cardiovascular and/or sedatory activity. These compounds of Formula 1 are useful as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2Badrenergic receptors. Compounds of Formula 1 where X is O also have the advantageous property that they have no or only minimal cardiovascular and/or sedatory activity and are useful for treating pain and other conditions with no or only minimal cardiovascular and/or sedatory activity.
REFERENCES:
patent: 3996366 (1976-12-01), Baker et al.
patent: 4798834 (1989-01-01), Merritt et al.
patent: 4977174 (1990-12-01), Stein et al.
patent: 5441970 (1995-08-01), Reitz et al.
patent: 5648373 (1997-07-01), Winkler et al.
patent: 5861420 (1999-01-01), Reitz et al.
patent: 5929103 (1999-07-01), Yoon et al.
patent: 5932742 (1999-08-01), Yoon et al.
patent: 6043373 (2000-03-01), Yoo et al.
patent: 6313172 (2001-11-01), Chow et al.
patent: 6465486 (2002-10-01), Baxter et al.
patent: 6534542 (2003-03-01), Chow et al.
patent: 6545182 (2003-04-01), Chow et al.
patent: 7091232 (2006-08-01), Chow et al.
patent: 7141597 (2006-11-01), Chow et al.
patent: 7183305 (2007-02-01), Dolby et al.
patent: 7345077 (2008-03-01), Chow et al.
patent: 7419994 (2008-09-01), Chow et al.
patent: 7569584 (2009-08-01), Heidelbaugh et al.
patent: 2002/0094998 (2002-07-01), Burke et al.
patent: 1 499 485 (1978-02-01), None
patent: WO 92/00073 (1992-01-01), None
patent: WO 99/28300 (1999-06-01), None
patent: WO 01/00586 (2001-01-01), None
patent: WO 02/36162 (2002-05-01), None
patent: WO 03/099795 (2003-12-01), None
Burke et al (2002): STN International HCAPLUS database, Columbus (OH), accession No. 2002: 353314.
Berque et al., Allyltitanates in Stereospecific Additions of Chiral o-Lactol: Efficient Enantioselective Route to a Potential Precursor of the C1-C9 Portion of Tylonolide, J. Org. Chem., 1999, 373-381.
Ciufolini et al., The Total Synthesis of Cystodytins, J. Amer. Chem. Soc., 1991, 113, 8016-8024.
Conklin et al., Substitution of three amino acids switches receptor specificity of Gpa to that of Gla Nature, 1993, p. 274-276, 363.
Cooke et al., Silicon in Synthesis, 8.1Vinyltrimethylsilane, a convenient ethylene equivalent for the Synthesis of Vinyl Aryl Sulfides, Vinyl Aryl Sulfoxides, Thiosilketene Acetals, and Fused Cyclopentenones, J. Org. Chem., 1980, 45, 1046-1053.
Corey et al., A new chiral catalyst for the enantioselective synthesis of secondary alcohols and deuterated primary alcohols by carbonyl reduction, Tetrahedron Letters, 1989, 30, 6275-6278.
Dirig, et al., Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli, J. Neurosci. Methods, 1997, 76, p. 183-191.
Dixon et al., Efficient Analysis of Experimental Observations, Ann. Rev. Pharmacol. Toxicol., 1980, 20, p. 441-462.
Hargreaves, et al., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 1988, 32, p. 77-88.
Horne et al., A two-step synthesis of imidazoles from aldehydes via 4-tosyloxazolines, Heterocycles, 1994, 39, 139.
Hua et al., A one-pot condensation of pyrones and enals. Synthesis of 1H, 7H-5a, 6, 8, 9-Tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans J. Org. Chem. 1997, 62, 6888-6896.
Huang et al., The Improved Preparation of 7,8-dihydro-quinoline-5(gH)-One and 6,7-dihydro-6H-1-pyrindin-5-one, Synthetic Communications, 1998, 28, 1197-1200.
Jackman, et al. (1949): STN International CAPLUS data base, Columbus, Ohio, Accession No. 1949:2664.
Jenneskens, et al., Flash vacuum thermolysis of 5,6,8,9-tetrahydro-4′-methylenesprio[7H-benzocycloheptene-7,1′-cyclohexa-2′5′-diene]. The intermediate formation of [3,2]orthoparacyclophane, J. Org. Chem. 1986, 51, 2162-2168.
Kim et al., an experimental model for peripheral neuropathy produced by segmental spinal nerve litigation in the rat, Pain, 1992, 150, p. 355-363.
Kim et al., A facile synthesis of a-chloro enones by oxidative chlorination, Synthesis, 1993, 283.
Kowalski et al., a-Keto dianion precursors via conjugate additions to cyclic a bromo enones, J. Org. Chem., 1982, 47, 5088-5093.
Lemke et al., Synthesis of 5,6-dihydro-8(7H)-quinolinone thiosemicarbazones as potential antitumor agents, J. Med. Chem., 1977,20,10,1351.
Mancuso, Activated dimethyl sulfoxide: useful reagents for synthesis, Synthesis, 1981, p. 165.
Messier et al., High throughput Assays of cloned adrenegeric, muscarinic, neurokinin, and neurotrophin receptors in living mammalian cells, Pharmacol. Toxicol., 1995,75,308-311.
Molina et al., Vinyliminophosphorane-mediated preparation of 2-aryiquinoline and 4-aryl-1-azaanthraquinone derivatives, x-ray crystal structure of 1,2-dihydro-3H-indazolo[2,3-a]quinolin-4-one, Tetrahedron, 1995,51, 1265-1276.
Organ et al., Ni-catalyzed cross coupling of alkoxide-containing vinyl halides with Grignard reagents. A “one-pot” synthesis of 2-[trimethylsily]-2-propen-1-yl acetate, J. Org. Chem., 1997, 62, 1523-1526.
Sosa et al., Synthesis of axinohydantoins, J. Org. Chem., 2002, 67, 4498-4500.
Woods et al., Synthesis with Dihydrorescorcinol mono ethyl ether: 3-alkykl-a2-cyclohexenones, J. Amer. Chem. Soc., 1949,71, 2028-2031.
Xavier et al., (s)-tetahydro-1-methy1-3,3-diphenyl-1H, 3H-pyrrolo-[1,2-c][1,3,2]oxazaborolen7)-,[1-4-(3aS-cls)]-), Organic Synthesis, 1996, 50, 74.
Yoon, et al. (1998):STN International CAPLUS data base, Columbus, Ohio, Accession No. 1998: 147327.
Chow Ken
Garst Michael
Gil Daniel
Gomez Dario G.
Heidelbaugh Todd
Allergan Inc.
Allergan, Inc.
Ene Doina G.
Shameem Golam M M
LandOfFree
4-(substituted cycloalkylmethyl) imidazole-2-thiones,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(substituted cycloalkylmethyl) imidazole-2-thiones,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(substituted cycloalkylmethyl) imidazole-2-thiones,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4300997